Kelyniam Global (Kelyniam Global) Gross-Profit-to-Asset % : 30.53% (As of Mar. 2008)

View and export this data going back to 2008. Start your Free Trial

What is Kelyniam Global Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Kelyniam Global's annualized Gross Profit for the quarter that ended in Mar. 2008 was $0.02 Mil. Kelyniam Global's average Total Assets over the quarter that ended in Mar. 2008 was $0.07 Mil. Therefore, Kelyniam Global's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2008 was 30.53%.

Kelyniam Global Gross-Profit-to-Asset % Historical Data

The historical data trend for Kelyniam Global's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kelyniam Global Gross-Profit-to-Asset % Chart

Kelyniam Global Annual Data

Trend

Dec06

Dec07

Gross-Profit-to-Asset %

82.14

61.84

Kelyniam Global Quarterly Data
	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08
Gross-Profit-to-Asset %	Get a 7-Day Free Trial			116.36	48.65	34.53	40.00	30.53

Competitive Comparison of Kelyniam Global's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Kelyniam Global's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kelyniam Global's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Kelyniam Global's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Kelyniam Global's Gross-Profit-to-Asset % falls into.

Kelyniam Global Gross-Profit-to-Asset % Calculation

Kelyniam Global's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2007 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2007 )	/	( (Total Assets (A: Dec. 2006 )	+	Total Assets (A: Dec. 2007 ))	/ count )
	=	0.047	/	( (0.084	+	0.068)	/ 2 )
	=	0.047	/	0.076
	=	61.84 %

Kelyniam Global's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2008 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Mar. 2008 )	/	( (Total Assets (Q: Dec. 2007 )	+	Total Assets (Q: Mar. 2008 ))	/ count )
	=	0.02	/	( (0.068	+	0.063)	/ 2 )
	=	0.02	/	0.0655
	=	30.53 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2008) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Kelyniam Global Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Kelyniam Global's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kelyniam Global (Kelyniam Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kelyniam Global Inc (OTCPK:KLYG) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

97 River Road, Suite A, Canton, CT, USA, 06019

Website

https://www.kelyniam.com

Kelyniam Global Inc is a medical device manufacturing company that specializes in the production of custom skull implants utilizing computer-aided design and bio-compatible medical grade polymers.